InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,998.18
(
0.24%
)
US TECH 100
20,530.88
(
0.07%
)
Dow Jones
44,022.50
(
0.25%
)
Brent Oil
71.78
(
0.22%
)
Bitcoin
91,132.28
(
3.65%
)
Post# of 416
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

nbm16yankees

Send PM Follow Ignore
Followers 15
Posts 544
Boards Moderated 0
Alias Born 01/13/2006

nbm16yankees

Re: None

Tuesday, 05/19/2015 10:19:07 AM

Tuesday, May 19, 2015 10:19:07 AM

Post# of 416
H.C. Wainwright Assigned a Buy Rating to Alliqua
By George Macdonald

In a report published on May 15, Swayampakula Ramakanth from H.C. Wainwright Assigned a Buy rating to Alliqua (NASDAQ: ALQA), with a price target of $11. The company’s shares closed last Friday at $4.48.

Alliqua has an analyst consensus of Strong Buy, with a price target consensus of $8.

The company has a one year high of $7.20 and a one year low of $3.70. Currently, Alliqua has an average volume of 90.85k.

According to TipRanks, Ramakanth is a 3-star analyst with an average return of 4.6% and a 28.1% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as IntelGenx Technologies, Sorrento Therapeutics, and Aldeyra Therapeutics.

Alliqua BioMedical Inc is a biomedical company providing wound care solutions. It is also engaged in contract manufacturing.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up